Orasis snags $78M to launch presbyopia eye drops more than a year after FDA approval

Last October was an FDA approval. This October is a $68 million fundraising round. Next year, maybe a drug launch.

Orasis Pharmaceuticals …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Novo Nordisk’s amylin pill leads to substantial weight loss in early study

Novo Nordisk on Tuesday reported that its new obesity pill that targets the amylin hormone led to substantial weight loss in an early study, boosting

September 10, 2024

Lykos Plots FDA Appeal: Reeling from CRL and Journal Article Retractions, MDMA Developer Hopes to Change Your Mind – Psychedelic Alpha

As I reported on Friday evening, Lykos looks set to appeal the FDA’s decision. The company said it will request a meeting with the agency to ask

August 13, 2024

Fancy Nasal Suction Device Makes Little Difference in Infant Bronchiolitis

Babies discharged from the emergency department (ED) for bronchiolitis saw mixed benefits from enhanced nasal suctioning, a randomized trial found. Additional resource use — a

October 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.